NCT04701528View on ClinicalTrials.gov

Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 15, 2020

Primary Completion Date

March 25, 2022

Study Completion Date

October 25, 2022

Conditions
Covid19Kidney Transplant Infection
Interventions
DRUG

Voclosporin

Temporarily switching of tacrolimus maintenance immunosuppression to voclosporin maintenance immunosuppression with possible additional anti-viral activity

DRUG

Tacrolimus

Comparator

Trial Locations (1)

2333 ZC

Leiden University Medical Center, Leiden

Sponsors
All Listed Sponsors
collaborator

Aurinia Pharmaceuticals Inc.

INDUSTRY

lead

Leiden University Medical Center

OTHER